Stabilization and reduction of tct of brines containing monovalent iodides
US-2019119548-A1 · Apr 25, 2019 · US
US11130898B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11130898-B2 |
| Application number | US-201916568951-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 12, 2019 |
| Priority date | Nov 29, 2018 |
| Publication date | Sep 28, 2021 |
| Grant date | Sep 28, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure provides methods and systems for treatment fluids including an iodide brine. In some embodiments of the present disclosure, an oil-based treatment fluid in the form of an invert emulsion comprising an aqueous internal phase and an oil external phase, wherein the aqueous internal phase comprises an iodide brine is provided. The treatment fluid may be introduced into at least a portion of a well bore penetrating at least a portion of a subterranean formation.
Opening claim text (preview).
What is claimed is: 1. A method comprising: providing a treatment fluid in the form of an invert emulsion comprising an aqueous internal phase and an oil external phase, wherein the aqueous internal phase comprises an iodide brine having a density at or above about 13 lb/gal, and wherein the iodide brine comprises at least one salt selected from the group consisting of: lithium iodide, sodium iodide, potassium iodide, rubidium iodide, cesium iodide, magnesium iodide, calcium iodide, barium iodide, and any combination thereof; and introducing the treatment fluid into at least a portion of a well bore penetrating at least a portion of a subterranean formation. 2. The method of claim 1 , wherein the treatment fluid further comprises a crystallization inhibitor. 3. The method of claim 2 wherein the crystallization inhibitor is selected from the group consisting of: alcohols, glycols, sugar alcohols, aldoses, ketoses, inorganic salts, amides, amino acids, sugar acids, any derivative thereof, and any combination thereof. 4. The method of claim 1 wherein the iodide brine has a density of about 13.3 lb/gal to about 18 lb/gal. 5. The method of claim 1 , wherein the treatment fluid further comprises an emulsifier. 6. The method of claim 5 , wherein the emulsifier is selected from the group consisting of: fatty amines, ethoxylated nonylphenols, fatty acids, fatty acid esters, tail oil, oxidized tall oil, modified tall oil, rosin acid, resin acid, any derivative thereof, and any combination thereof. 7. The method of claim 1 , wherein the treatment fluid further comprises an additional brine. 8. The method of claim 7 wherein the additional brine comprises at least one salt selected from the group consisting of: sodium chloride, sodium bromide, sodium formate, potassium formate, cesium formate, lithium bromide, potassium bromide, rubidium bromide, magnesium bromide, calcium bromide, calcium chloride, strontium bromide, zinc bromide, manganese (II) bromide, or any combinations thereof. 9. A method comprising: providing a water-based drill-in fluid, wherein the water-based drill-in fluid comprises an iodide brine, wherein the water-based drill-in fluid further comprises a viscosifier, and wherein the iodide brine comprises at least one salt selected from the group consisting of: lithium iodide, sodium iodide, potassium iodide, rubidium iodide, cesium iodide, magnesium iodide, calcium iodide, barium iodide, and any combination thereof; introducing the water-based drill-in fluid into at least a portion of a well bore penetrating at least a portion of a subterranean formation; and using the water-based drill-in fluid to drill at least the portion of the well bore to penetrate at least a reservoir portion of the subterranean formation. 10. The method of claim 9 wherein the water-based drill-in fluid has a density over about 14 lb/gal. 11. The method of claim 9 wherein the viscosifier is selected from the group consisting of: xanthan gum, crosslinked starch, modified starch, modified hydroxyethylcellulose, crosslinked hydroxyethylcellulose, biopolymers, synthetic polymer, any derivative thereof, and any combination thereof. 12. The method of claim 9 wherein the water-based drill-in fluid further comprises a crystallization inhibitor selected from the group consisting of: alcohols, glycols, sugar alcohols, aldoses, ketoses, inorganic salts, amides, amino acids, sugar acids, any derivative thereof, and any combination thereof. 13. The method of claim 9 , wherein the water-based drill-in fluid further comprises a fluid loss control additive. 14. The method of claim 9 , wherein the water-based drill-in fluid further comprises a weighting agent selected from calcium carbonate, magnesium carbonate, magnesium oxide, magnesium hydroxide, barite, manganese tetroxide, ilmenite, any derivative thereof, and any combination thereof. 15. The method of claim 9 , wherein the water-based drill-in fluid further comprises an additional brine. 16. The method of claim 15 wherein the additional brine comprises at least one salt selected from the group consisting of: sodium chloride, sodium bromide, sodium formate, potassium formate, cesium formate, lithium bromide, potassium bromide, rubidium bromide, magnesium bromide, calcium bromide, calcium chloride, strontium bromide, zinc bromide, manganese (II) bromide, or any combinations thereof. 17. A method comprising: providing an oil-based treatment fluid in the form of an invert emulsion comprising an aqueous internal phase and an oil external phase, wherein the aqueous internal phase comprises an iodide brine having a density at or above about 13 lb/gal, wherein the iodide brine comprises at least one salt selected from the group consisting of: lithium iodide, sodium iodide, potassium iodide, rubidium iodide, cesium iodide, magnesium iodide, calcium iodide, barium iodide, and any combination thereof; wherein the treatment fluid further comprises a crystallization inhibitor selected from the group consisting of: alcohols, glycols, sugar alcohols, aldoses, ketoses, inorganic salts, amides, amino acids, sugar acids, any derivative thereof, and any combination thereof; and introducing the treatment fluid into at least a portion of a well bore penetrating at least a portion of a subterranean formation.
Related publications grouped by family.
Answers are generated from the same data shown on this page.